Luisa R.
- Country
- Italy
- Department
- Allergologia e Immunologia Clinica
Research Overview
- Safety Evaluation of CHF5993 pMDI Formulated with HFA-152a Versus HFA-134a in Moderate to Severe Asthma Patients
- A 52-Week Randomized Double-Blind Trial Comparing CHF5993 (Beclometasone Dipropionate, Formoterol Fumarate, Glycopyrronium Bromide) to Fluticasone Propionate/Salmeterol in Adolescents with Uncontrolled Asthma
Data & Insights
Has run more than one trial at 2 of 136 partner sites.
Specializations
Respiratory Medicine
The investigator specializes in the clinical evaluation of therapeutic interventions for asthma management, with particular focus on patients with moderate to severe controlled asthma.
- Advanced Inhalation Therapy
- Respiratory Device Technology
- Asthma Control Assessment
Their expertise extends to evaluating novel propellant technologies in respiratory medicine delivery systems.
Treatment Optimization
The investigator focuses on advancing therapeutic approaches aligned with GINA Guidelines, specifically targeting Step 4 and Step 5 treatment protocols.
- Treatment Safety Assessment
- Therapeutic Equivalence Studies
- Clinical Response Evaluation
Their work encompasses the evaluation of innovative delivery systems for respiratory medications.
Clinical Assessment
The investigator conducts detailed evaluations of bronchial response to different therapeutic formulations in asthma treatment.
- Respiratory Function Testing
- Safety Profile Analysis
- Comparative Treatment Studies
Their research emphasizes the importance of safety assessment in new therapeutic delivery systems.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.